IN188843B - - Google Patents

Info

Publication number
IN188843B
IN188843B IN223MU2000A IN188843B IN 188843 B IN188843 B IN 188843B IN 223MU2000 A IN223MU2000 A IN 223MU2000A IN 188843 B IN188843 B IN 188843B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Shilpa Sudhakar Kocharekar
Original Assignee
Vinod Daftary Gautam Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vinod Daftary Gautam Dr filed Critical Vinod Daftary Gautam Dr
Priority to IN223MU2000 priority Critical patent/IN188843B/en
Priority to JP2002503255A priority patent/JP4804702B2/ja
Priority to KR1020027017441A priority patent/KR100812764B1/ko
Priority to RU2003101391/04A priority patent/RU2275899C2/ru
Priority to DE60127140T priority patent/DE60127140T2/de
Priority to ES01958366T priority patent/ES2283423T3/es
Priority to AU8008401A priority patent/AU8008401A/xx
Priority to US10/312,298 priority patent/US7053061B2/en
Priority to AU2001280084A priority patent/AU2001280084B2/en
Priority to PCT/IN2001/000119 priority patent/WO2001097778A2/fr
Priority to EP01958366A priority patent/EP1313449B1/fr
Priority to CNB018143318A priority patent/CN100502834C/zh
Priority to AT01958366T priority patent/ATE355825T1/de
Publication of IN188843B publication Critical patent/IN188843B/en
Priority to ZA200300330A priority patent/ZA200300330B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IN223MU2000 2000-06-22 2000-06-22 IN188843B (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IN223MU2000 IN188843B (fr) 2000-06-22 2000-06-22
US10/312,298 US7053061B2 (en) 2000-06-22 2001-06-19 Amphotercin B structured emulsion
AU2001280084A AU2001280084B2 (en) 2000-06-22 2001-06-19 Amphotericin b structured emulsion
RU2003101391/04A RU2275899C2 (ru) 2000-06-22 2001-06-19 Структурированная эмульсия амфотерицина b с низкой токсичностью для парентерального введения и способ ее получения
DE60127140T DE60127140T2 (de) 2000-06-22 2001-06-19 Amphotericin b enthaltende strukturierte emulsion
ES01958366T ES2283423T3 (es) 2000-06-22 2001-06-19 Emulsion estructurada de anfotericina b.
AU8008401A AU8008401A (en) 2000-06-22 2001-06-19 Amphotericin b structured emulsion
JP2002503255A JP4804702B2 (ja) 2000-06-22 2001-06-19 アムホテリシンb構造化エマルション
KR1020027017441A KR100812764B1 (ko) 2000-06-22 2001-06-19 구조화된 암포테리신 b 유제
PCT/IN2001/000119 WO2001097778A2 (fr) 2000-06-22 2001-06-19 Emulsion structuree d'amphotericine b
EP01958366A EP1313449B1 (fr) 2000-06-22 2001-06-19 Emulsion structuree d'amphotericine b
CNB018143318A CN100502834C (zh) 2000-06-22 2001-06-19 两性霉素b结构化乳剂
AT01958366T ATE355825T1 (de) 2000-06-22 2001-06-19 Amphotericin b enthaltende strukturierte emulsion
ZA200300330A ZA200300330B (en) 2000-06-22 2003-01-13 Amphotericin B Structured emulsion.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN223MU2000 IN188843B (fr) 2000-06-22 2000-06-22

Publications (1)

Publication Number Publication Date
IN188843B true IN188843B (fr) 2002-11-09

Family

ID=11097226

Family Applications (1)

Application Number Title Priority Date Filing Date
IN223MU2000 IN188843B (fr) 2000-06-22 2000-06-22

Country Status (13)

Country Link
US (1) US7053061B2 (fr)
EP (1) EP1313449B1 (fr)
JP (1) JP4804702B2 (fr)
KR (1) KR100812764B1 (fr)
CN (1) CN100502834C (fr)
AT (1) ATE355825T1 (fr)
AU (2) AU8008401A (fr)
DE (1) DE60127140T2 (fr)
ES (1) ES2283423T3 (fr)
IN (1) IN188843B (fr)
RU (1) RU2275899C2 (fr)
WO (1) WO2001097778A2 (fr)
ZA (1) ZA200300330B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515181A (pt) * 2004-09-13 2008-07-22 Bharat Serums & Vaccines Ltd composição de óleo-em-água estéril para administração intravenosa, uso de um monoglicerìdeo e processo de preparação de uma composição para administração intravenosa
KR20160029866A (ko) * 2007-05-25 2016-03-15 더 유니버시티 오브 브리티쉬 콜롬비아 치료제의 경구 투여를 위한 제제 및 관련 방법
JP2012504135A (ja) * 2008-09-27 2012-02-16 ジャイナ ファーマシューティカルズ,インコーポレーテッド 経口適用および局所適用のための脂質系薬学的調製物、ならびにそれらの組成物、方法、および使用
US20100209512A1 (en) * 2009-02-13 2010-08-19 Stable Solutions Llc Particle size-structured parenteral dispersions
WO2011050457A1 (fr) 2009-10-26 2011-05-05 The University Of British Columbia Formulation stabilisée pour administration orale d'agents thérapeutiques et méthodes afférentes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
GB8714652D0 (en) * 1987-06-23 1987-07-29 Davis S S Drug emulsion
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JPH04173736A (ja) * 1990-11-06 1992-06-22 Nippon Shinyaku Co Ltd 乳化剤
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
GB9426104D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Use of surfactants and emulsions
JPH1160491A (ja) * 1997-08-25 1999-03-02 Yoshitomi Pharmaceut Ind Ltd アムホテリシンb含有製剤
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe

Also Published As

Publication number Publication date
WO2001097778A2 (fr) 2001-12-27
AU2001280084B2 (en) 2005-11-17
CN1447682A (zh) 2003-10-08
KR100812764B1 (ko) 2008-03-12
ZA200300330B (en) 2004-04-08
ES2283423T3 (es) 2007-11-01
AU8008401A (en) 2002-01-02
CN100502834C (zh) 2009-06-24
RU2275899C2 (ru) 2006-05-10
US20030206929A1 (en) 2003-11-06
WO2001097778A3 (fr) 2002-05-30
DE60127140D1 (de) 2007-04-19
DE60127140T2 (de) 2007-12-13
JP4804702B2 (ja) 2011-11-02
EP1313449B1 (fr) 2007-03-07
EP1313449A2 (fr) 2003-05-28
ATE355825T1 (de) 2007-03-15
US7053061B2 (en) 2006-05-30
KR20030039331A (ko) 2003-05-17
JP2004525068A (ja) 2004-08-19
WO2001097778A8 (fr) 2003-06-26

Similar Documents

Publication Publication Date Title
AR028236A3 (fr)
JP2003514210A5 (fr)
JP2001279066A5 (fr)
JP2001260669A5 (fr)
JP2002162296A5 (fr)
IN188843B (fr)
JP2002064760A5 (fr)
JP2002127453A5 (fr)
JP2001296479A5 (fr)
JP2001227213A5 (fr)
JP2003504782A5 (fr)
CN3145461S (fr)
CN3141860S (fr)
CN3141409S (fr)
CN3151057S (fr)
CN3150564S (fr)
CN3150409S (fr)
CN3149762S (fr)
CN3149303S (fr)
CN3148615S (fr)
CN3148479S (fr)
CN3147656S (fr)
CN3147473S (fr)
CN3141406S (fr)
CN3152302S (fr)